How Wellthy Therapeutics
enabled evidence based remote care for a Leading health insurance provider?

Chronic Diseases are projected to account for 53% of all deaths in India. Deaths from chronic disease patients are poised to grow at 18% and specific to diabetes will increase by 35%. The rise of chronic diseases imposes a huge health risk and economic burden over the healthcare industry. With the onset of Covid-19, the Health insurance firm wanted to provide additional care – personalized, remote care to its chronic disease insured or diagnosed patients with the goal to improve health and economic outcomes for its insurers

Register Now to download the complete Case Study!


At Wellthy Therapeutics our task was to manage chronic disease insured or diagnosed patients to effectively manage their chronic illness during Covid-19. Objective was to reduce exposure risk with physician or lab visits and at the same time provide protocol driven on demand care to remote patients.


Wellthy Therapeutics enrolled patients with cardio-metabolic chronic conditions onto a six month program





To showcase the effectiveness of protocol driven Virtual care pathways delivered via Wellthy CARE ™ Platform during Covid 19 Pandemic and contain exposure/risk with limited Clinic or Hospital Visits


The study demonstrates a significant improvement in HBA1C levels of more than 60% of enrolled patients with protocol driven virtual engagement.

Download the full report here!!